The disparity in HPV cancer prevention and
care is unacceptable. A huge gap in vaccinations exists in Canada's
North
By Gilla
Shapiro,
Juliet Guichon
and Zeev Rosberger
Juliet Guichon
and Zeev Rosberger
MONTREAL,
Que./Troy Media/ - The human papillomavirus (HPV) vaccine should be
available to all Canadian children. However, the children of the North still
don't have
universal access to this life-saving vaccine.
Now that
Newfoundland and Labrador has announced funding for the
HPV vaccine for boys,
all children in Canada's 10 provinces have
access to the vaccine that helps
prevent cancer. This is great news.
But unfortunately for children in the North,
the governments of
Northwest Territories, Nunavut and Yukon have not yet made
this
disease-preventing and life-saving decision.
That no
Canadian territory offers the HPV vaccine to boys is
unjust for at least five
reasons:
- Boys need the HPV vaccine. The Canadian Cancer Society reports that the majority of head and neck cancer patients are male and the numbers are rising more quickly in males than females.
- Boys have a special need for HPV prevention. Whereas females have Pap tests to detect early cervical cancer, there is no similar program for males to detect head and neck cancers. Consequently, the Canadian Medical Association, Canadian Paediatric Society and Canadian Cancer Society, among other medical organizations, recommend males be vaccinated against HPV.
- Children in the North don't have the same population with HPV immunity as in the south. Territorial government reports and parental surveys reveal that their girls are the least likely of all Canadian girls to be vaccinated against HPV. Territorial low female vaccine coverage rates reduce the likelihood that boys will be protected through herd immunity - the protection offered to non-vaccinated people by those who are vaccinated.
- The territories' people have a greater need for HPV prevention. Research demonstrates that aboriginal people have a higher prevalence of HPV infection and disease than non-aboriginal peoples. Although data is limited and differences among First Nations, Métis and Inuit populations are rarely identified, it appears that the larger HPV disease burden in aboriginal peoples results from unequal access to prevention and screening service.
- Cancer prevention is especially important where there are great distances between people and tertiary cancer care, as exist in the North.
Provincial
and territorial governments usually make vaccine funding decisions. The
territories' relatively small populations and vast land mass present unique
funding challenges, not least because the territories have the lowest gross
domestic product per capita. The federal government could help advance equity in
health outcomes across Canada by funding HPV vaccination for boys.
The Truth
and Reconciliation Commission's report called on Parliament to close the health
gaps between aboriginal and non-aboriginal communities in a number of areas,
including chronic disease, life expectancy and the availability of appropriate
health services. The federal government can help reduce chronic disease and
increase life expectancy by making available to all children an appropriate
preventive health measure. Such a decision would reduce the need for people to
seek medical care, reducing health spending.
The
disparity in HPV cancer prevention and care is unacceptable. Canada can do
better. If Canada were to vaccinate all boys and girls against HPV, it would
join Australia, Austria, Israel, Italy and Switzerland in taking such measures
to prevent HPV-related cancers in a generation of children.
Former NDP
leader and medicare's founding father Tommy Douglas said, "My dream is for
people around the world to look up and to see Canada like a little jewel sitting
at the top of the continent." It's time for the federal government to help all
Canadian children avoid the suffering of HPV-related disease by funding
vaccination for Northwest Territories, Nunavut and Yukon boys.
Gilla
Shapiro is a doctoral candidate at McGill University and a Vanier Canada
Graduate Scholar. Juliet Guichon is assistant professor, Cumming School of
Medicine, University of Calgary. Zeev Rosberger is an associate professor,
department of psychology and faculty of medicine, McGill University and Jewish
General Hospital.
© 2017 Distributed by Troy
Media
No comments:
Post a Comment
id="blogfeeds"><$BlogFeedsVertical$>
id="postfeeds"><$BlogItemFeedLinks$>